Pacific Biosciences of California PACB Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Pacific Biosciences of California in its filing.
Tagged under the XBRL concept us-gaap:ShortTermInvestments.
The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacific Biosciences of California's short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacific Biosciences of California's short-term investments?
- Pacific Biosciences of California (PACB) reported short-term investments of $219.69M in Q1 2026.
- How has Pacific Biosciences of California's short-term investments changed year-over-year?
- Pacific Biosciences of California's short-term investments decreased by 22.8% year-over-year, from $284.6M to $219.69M.
- What is the long-term trend for Pacific Biosciences of California's short-term investments?
- Over 5 years (2020 to 2025), Pacific Biosciences of California's short-term investments has grown at a -3.3% compound annual growth rate (CAGR), from $255.21M to $215.8M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.